STAT11h
Previewing Immunovant’s myasthenia gravis study readout — with all its quirky nuance
It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.
Immunovant’s Promising Pipeline: Strategic Advances in FcRn Inhibitors and Market Expansion
Analyst Sam Slutsky of LifeSci Capital maintained a Buy rating on Immunovant (IMVT – Research Report), retaining the price target of ...
Immunovant’s Strategic Advancements and Market Potential Highlighted in Buy Rating
Analyst Brian Cheng of J.P. Morgan maintained a Buy rating on Immunovant (IMVT – Research Report), with a price target of $46.00.Invest with ...
Frontiers23d
Exploring the clinical significance of anti-acetylcholine receptor antibody titers, changes, and change rates in Myasthenia Gravis
1 Department of Neurology, Wuhan No. 1 Hospital, Wuhan, China 2 The First Clinical Medical Institute, Hubei University of Chinese Medicine, Wuhan, China Introduction/Aims: Myasthenia Gravis (MG ...
CNN-News1825d
Signs and Symptoms of Thyroid Disorders You Shouldn't Ignore
Dr. Nisha Kaimal, Consultant, Endocrinology and Diabetology, Kokilaben Dhirubhai Ambani Hospital, Mumbai essentially highlights the important aspects of thyroid disease and their symptoms which must ...
BMJ26d
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK’s first real-world experience
Background We report our experience of patients with generalised myasthenia ... (Myasthenia Gravis Foundation of America’s (MGFA) Clinical Classification Class IIIa to IVb) and its use was to be ...
Business Wire28d
Cyrus Biotechnology Announces Selection of CYR212 as Clinical Candidate for Chronic IgG-driven Autoimmune Disease Including Myasthenia Gravis and Immune Thrombocytopenia
An example is generalized Myasthenia Gravis (gMG) where IgG targets neuromuscular receptor proteins leading to degenerative neurological disease. In Immune Thrombocytopenia (ITP), IgG targets ...